From The Medical Letter on Drugs and Therapeutics
October 15, 2014

Drugs for MRSA Skin and Soft-Tissue Infections

Author Affiliations

Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2014;312(15):1583-1584. doi:10.1001/jama.2014.13385

Methicillin-resistant Staphylococcus aureus (MRSA), which was traditionally a nosocomially-acquired organism but now frequently occurs in the absence of health care exposure, is the predominant cause of suppurative skin and soft-tissue infections in many parts of the US.1,2 Community-associated MRSA usually causes furunculosis, purulent cellulitis, and abscesses, but necrotizing fasciitis, necrotizing pneumonia, and sepsis can also occur.

First Page Preview View Large
First page PDF preview
First page PDF preview